26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

c allotype<br />

A rabbit immunoglobulin λ light chain allotype 100 designated<br />

as c7 and c21.<br />

C domain<br />

Refer to constant domain.<br />

C gene<br />

DNA encoding the constant region of immunoglobulin<br />

heavy and light polypeptide chains. The heavy chain C gene<br />

is comprised of exons that encode the different homology<br />

regions of the heavy chain.<br />

C gene segment<br />

DNA coding for a T cell receptor or an immunoglobulin<br />

polypeptide chain constant region. One or more exons<br />

may be involved. Constant region gene segments comprise<br />

immunoglobulin and T cell receptor gene loci DNA<br />

sequences that encode TCR α and β chains and nonvariable<br />

regions of immunoglobulin heavy and light polypeptide<br />

chains.<br />

C region<br />

Refer to constant region.<br />

C region (constant region)<br />

Abbreviation for the constant region carboxyl terminal portion<br />

of immunoglobulin heavy or light polypeptide chain<br />

that is identical in a particular class or subclass of immunoglobulin<br />

molecules. C H designates the constant region of<br />

the heavy chain of immunoglobulin, and C L designates the<br />

constant region of the light chain.<br />

C segment<br />

An exon that encodes an immunoglobulin molecule’s constant<br />

region domain.<br />

s<br />

R<br />

S<br />

R<br />

C1 Complex<br />

C1 Complex.<br />

C<br />

C1<br />

A 750-kDa multimeric molecule comprised of one C1q, two<br />

C1r, and two C1s subcomponents. The classical pathway of<br />

complement activation begins with the binding of C1q to<br />

immunoglobulin M (IgM) or IgG molecules. C1q, C1r, and<br />

C1s form a macromolecular complex in a Ca 2+ -dependent<br />

manner. The 400-kDa C1q molecule possesses three<br />

separate polypeptide chains that unite into a heterotrimeric<br />

structure resembling a stem that contains an amino terminal<br />

in triple helix and a globular structure at the carboxyl<br />

terminus resembling a tulip. Six of these tulip-like structures<br />

with globular heads and stems form a circular and<br />

symmetric molecular complex in the C1q molecule that has<br />

a central core. The serine esterase molecules designated C1r<br />

and C1s are needed for the complement cascade to progress.<br />

These single chain 85-kDa proteins unite in the presence<br />

of calcium to produce a tetramer comprised of two C1r and<br />

two C1s subcomponents to form a structure that is flexible<br />

and has a C1s–C1r–C1r–C1s sequence. When at least two<br />

C1q globular regions bind to IgM or IgG molecules, the C1r<br />

in a tetramer associated with the C1q molecule becomes<br />

activated, leading to splitting of the C1r molecules in the<br />

tetramer with the formation of 57- and a 28-kDa chains.<br />

The latter, termed C1r, functions as a serine esterase, splitting<br />

the C1s molecules into 57- and 28-kDa chains. The<br />

28-kDa chain derived from the cleavage of C1s molecules,<br />

designated C1s, also functions as a serine esterase, cleaving<br />

C4 and C2 and causing progression of the classical complement<br />

pathway cascade.<br />

C1 deficiencies<br />

Only a few cases of C1q, C1r, or C1r and C1s deficiencies<br />

have been reported. The deficiencies have an autosomal-recessive<br />

mode of inheritance. Patients with these defects may<br />

manifest systemic lupus erythematosus (SLE), glomerulonephritis,<br />

or pyogenic infections. They exhibit increased<br />

incidence of type III (immune complex) hypersensitivity<br />

diseases. Half of C1q-deficient persons may contain physiologic<br />

levels of mutant C1q that are not functional.<br />

C1 esterase inhibitor<br />

A serum protein that counteracts activated C1. This diminishes<br />

the generation of C2b which facilitates development<br />

of edema.<br />

C1 inhibitor (C1 INH)<br />

A 478-amino acid residue, single polypeptide chain protein<br />

in the serum. It blocks C1r activation, prevents C1r cleavage<br />

of C1s, and inhibits C1s splitting of C4 and C2. The<br />

molecule is highly glycosylated, with carbohydrates making<br />

up approximately one half of its content. It contains seven<br />

O-linked oligosaccharides linked to serine and six N-linked<br />

oligosaccharides tethered to an asparagine residue. Besides<br />

its effects on the complement system, C1 INH blocks factors<br />

in the blood clotting system, including kallikrein, plasmin,<br />

121<br />

C

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!